Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04828798 · ClinicalTrials.gov registry record · NA

Directional Versus Nondirectional DBS for ET

A NA study of Essential Tremor, sponsored by Oregon Health and Science University.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT04828798 is a NA study of Essential Tremor that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 24 participants, below the 402-participant average among 41 other Essential Tremor trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04828798, a NA study of Essential Tremor, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

This will be a single center (OHSU) proof of concept trial to demonstrate that directional deep brain stimulation (DBS) creates a larger therapeutic window for the treatment of essential tremor (ET), effectively treats ET, and minimizes effects on speech, gait and balance compared to nondirectional DBS.

Conditions Studied

Interventions

  • DEVICE Deep brain stimulation of the VIM Thalamic nuclei

Study Locations (1)

Oregon

  • Oregon Health & Science University - Portland

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2021-04-01
Est. Completion 2029-10-01
Phase NA

What the Registry Record Tells You About NCT04828798

The ClinicalTrials.gov registry entry for NCT04828798 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 402-participant average among 41 other Essential Tremor trials with a reported enrollment target (94% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Essential Tremor appearing as the primary indexed condition, and to 1 intervention - of which Deep brain stimulation of the VIM Thalamic nuclei is the first listed.

NCT04828798 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT04828798 about?

NCT04828798 is a clinical study titled "Directional Versus Nondirectional DBS for ET". This will be a single center (OHSU) proof of concept trial to demonstrate that directional deep brain stimulation (DBS) creates a larger therapeutic window for the treatment of essential tremor (ET), effectively treats ET, and minimizes effects on speech, gait and balance compared to nondirectional ...

What is the current status of trial NCT04828798?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2021-04-01. Estimated completion is 2029-10-01.

What conditions does trial NCT04828798 study?

This clinical trial studies the following conditions: Essential Tremor.

What interventions are being tested in trial NCT04828798?

The interventions under investigation include: Deep brain stimulation of the VIM Thalamic nuclei (DEVICE).

Who is sponsoring clinical trial NCT04828798?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04828798 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Essential Tremor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.